Marwood L
Compass Pathfinder Ltd. (A Subsidiary of Compass Pathways PLC), London, UK.
ArticlePsilocybin
Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder.
ArticlePsilocybin
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
ArticlePsilocybin
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
ArticlePsilocybin
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
ArticlePsilocybin
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
ArticlePsilocybin
Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression
ArticlePsilocybin
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
ArticlePsilocybin
Unblinding and demand characteristics in the treatment of depression.
ArticlePsilocybin